This study aimed to investigate the potential correlation between the CYP2B6*9 (G516T, rs3745274) SNP and B-CLL susceptibility, as well as the effect of this connection on the clinical outcome after cyclophosphamide treatment among Egyptians. Here, CYP2B6 is linked to B-cell chronic lymphocytic leukemia.